Helen Luikart
Overview
Explore the profile of Helen Luikart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wayda B, Luikart H, Weng Y, Zhang S, Neidlinger N, Patrick Wood R, et al.
J Heart Lung Transplant
. 2025 Mar;
PMID: 40088959
Background: Most donor hearts offered for heart transplant (HT) in the United States (US) are turned down. We aimed to understand the reasons for this - focusing on those related...
2.
Wayda B, Luikart H, Weng Y, Zhang S, Nicely B, Nieto J, et al.
Eur J Heart Fail
. 2025 Feb;
PMID: 40012271
No abstract available.
3.
Wayda B, Weng Y, Zhang S, Luikart H, Pearson T, Nieto J, et al.
Circ Heart Fail
. 2024 Sep;
17(10):e011360.
PMID: 39308397
Background: Despite a shortage of potential donors for heart transplant in the United States, most potential donor hearts are discarded. We evaluated predictors of donor heart acceptance in the United...
4.
Henricksen E, Wayda B, Teuteberg J, Luikart H, Njoroge J, Guenthart B, et al.
J Heart Lung Transplant
. 2024 Aug;
44(1):75-81.
PMID: 39122221
Background: Patients of advanced age are often considered to be poor candidates for heart transplant (HT). As the U.S. population continues to age, it is important for clinicians to understand...
5.
Bhowmik A, Wayda B, Luikart H, Weng Y, Zhang S, Patrick Wood R, et al.
J Heart Lung Transplant
. 2024 Aug;
43(11):1833-1837.
PMID: 39089606
The use of 50+ year-old donors for heart transplant (HT) is rare in the United States. We assessed reasons for this-and whether it reflects concern about age itself or associated...
6.
Keller M, Sun J, Alnababteh M, Ponor L, Shah P, Mathew J, et al.
Transplant Direct
. 2024 Jul;
10(7):e1669.
PMID: 38953039
Background: A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral lung transplant recipients. In this multicenter prospective cohort study,...
7.
Keller M, Newman D, Alnababteh M, Ponor L, Shah P, Mathew J, et al.
J Heart Lung Transplant
. 2024 May;
43(9):1374-1382.
PMID: 38705500
Background: Lung transplant recipients are traditionally monitored with pulmonary function testing (PFT) and lung biopsy to detect post-transplant complications and guide treatment. Plasma donor-derived cell free DNA (dd-cfDNA) is a...
8.
Wang D, Tediashvili G, Kim D, Hu X, Luikart H, Renne T, et al.
J Heart Lung Transplant
. 2024 Apr;
43(8):1336-1347.
PMID: 38670297
Background: Cardiac allograft vasculopathy (CAV) remains the leading cause of long-term graft failure and mortality after heart transplantation. Effective preventive and treatment options are not available to date, largely because...
9.
Tapaskar N, Wayda B, Malinoski D, Luikart H, Groat T, Nguyen J, et al.
JACC Heart Fail
. 2024 Jan;
12(4):722-736.
PMID: 38244008
Background: Potential organ donors often exhibit abnormalities on electrocardiograms (ECGs) after brain death, but the physiological and prognostic significance of such abnormalities is unknown. Objectives: This study sought to characterize...
10.
Han J, Rushakoff J, Moayedi Y, Henricksen E, Lee R, Luikart H, et al.
J Heart Lung Transplant
. 2023 Oct;
43(3):387-393.
PMID: 37802261
Methods: Consecutive adult HT recipients (n = 596) from 1/2015 to 12/2019 at 2 US centers were included. Severity of PGD was based on the 2014 International Society for Heart...